BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1107 related articles for article (PubMed ID: 31725581)

  • 1. Patterns of Care and Comparison of Outcomes Between Primary Anal Squamous Cell Carcinoma and Anal Adenocarcinoma.
    Malakhov N; Kavi AM; Lee A; Adedoyin P; Sheth N; Lederman AJ; Schreiber D
    Dis Colon Rectum; 2019 Dec; 62(12):1448-1457. PubMed ID: 31725581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage Abdominoperineal Resection for Anal Squamous Cell Carcinoma: Use, Risk Factors, and Outcomes in a Canadian Population.
    Patel SV; Ko G; Raphael MJ; Booth CM; Brogly SB; Kalyvas M; Li W; Hanna T
    Dis Colon Rectum; 2020 Jun; 63(6):748-757. PubMed ID: 32384405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definitive Chemoradiation for Rectal Cancer: Is There a Role for Dose Escalation? A National Cancer Database Study.
    Wegner RE; Hasan S; Renz PB; Raj MS; Monga DK; Finley GG; Kirichenko AV; McCormick JT
    Dis Colon Rectum; 2019 Nov; 62(11):1336-1343. PubMed ID: 31567930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anal Cancers in Previously Screened Versus Unscreened Patients: Tumor Stage and Treatment Outcomes.
    Walker RJB; Easson AM; Hosni A; Kim J; Weiss ES; Santiago AT; Chesney TR; Salit IE
    Dis Colon Rectum; 2024 Jan; 67(1):32-41. PubMed ID: 37787557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Decision Support for High-Risk Stage II Colon Cancer: A Real-World Study of Treatment Concordance and Survival.
    Chen PJ; Li TL; Sun TT; Willis VC; Roebuck MC; Bravata DM; Liu XZ; Arriaga YE; Dankwa-Mullan I; Wu AW
    Dis Colon Rectum; 2020 Oct; 63(10):1383-1392. PubMed ID: 32969881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple High-Risk Features for Stage II Colon Carcinoma Portends Worse Survival Than Stage III Disease.
    Hajirawala LN; Yi Y; Herritt BC; Laurent ME; Klinger AL; Orangio GR; Davis KG; Barton JS
    Dis Colon Rectum; 2023 Aug; 66(8):1076-1084. PubMed ID: 35239528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors and Outcomes of Upstaging in Rectal Cancer Patients Who Did Not Receive Preoperative Therapy.
    Antunez AG; Kanters AE; Regenbogen SE
    Dis Colon Rectum; 2023 Jan; 66(1):59-66. PubMed ID: 35905174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Stratification Using Neoadjuvant Rectal Score in the Era of Neoadjuvant Chemoradiotherapy: Validation With Long-term Outcome Data.
    Lim YJ; Song C; Jeon SH; Kim K; Chie EK
    Dis Colon Rectum; 2021 Jan; 64(1):60-70. PubMed ID: 33306532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Size Criteria Is Not Sufficient in Selecting Patients for Local Excision Versus Radical Excision for Rectal Neuroendocrine Tumors >2 cm: A National Cancer Database Analysis.
    Izquierdo KM; Humphries MD; Farkas LM
    Dis Colon Rectum; 2021 Apr; 64(4):399-408. PubMed ID: 33651006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Patient-Reported Outcomes in Patients With Anal Squamous-Cell Cancer Undergoing Combined Modality Therapy.
    Taylor JP; Wei IH; Joshua Smith J; Tin AL; Aiken N; Vickers AJ; Romesser PB; Crane CH; Widmar M; Nash GM; Weiser MR; Paty PB; Garcia-Aguilar J; Pappou E
    Dis Colon Rectum; 2022 Dec; 65(12):1448-1455. PubMed ID: 36102865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socioeconomic Disparities in Anal Cancer: Effect on Treatment Delay and Survival.
    Nepal P; Zafar MH; Liu LC; Xu Z; Abdulhai MA; Perez-Tamayo AM; Chaudhry V; Mellgren AF; Gantt GA
    Dis Colon Rectum; 2024 Jun; 67(6):773-781. PubMed ID: 38411981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is High-Grade Tumor Budding an Independent Prognostic Factor in Stage II Colon Cancer?
    Kyong Shin J; Ah Park Y; Wook Huh J; Hyeon Yun S; Cheol Kim H; Yong Lee W; Hyung Kim S; Yun Ha S; Cho YB
    Dis Colon Rectum; 2023 Aug; 66(8):e801-e808. PubMed ID: 35394982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Patients With Local Regrowth After Nonoperative Management of Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Cotti GC; Pandini RV; Braghiroli OFM; Nahas CSR; Bustamante-Lopez LA; Marques CFS; Imperiale AR; Ribeiro U; Salvajoli B; Hoff PM; Nahas SC
    Dis Colon Rectum; 2022 Mar; 65(3):333-339. PubMed ID: 34775415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Impact of Lymphatic Invasion, Venous Invasion, Perineural Invasion, and Tumor Budding in Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision.
    Kim S; Huh JW; Lee WY; Yun SH; Kim HC; Cho YB; Park YA; Shin JK
    Dis Colon Rectum; 2023 Jul; 66(7):905-913. PubMed ID: 35195558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Survival With ypT0N+ Following Neoadjuvant Therapy in Rectal Cancer.
    Elshami M; Goldstone RN; Blaszkowsky LS; Cusack JC; Hong TS; Wo JY; Qadan M
    Dis Colon Rectum; 2022 Oct; 65(10):1224-1231. PubMed ID: 35714358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
    Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence Rate and Risk Factors for Anal Squamous Cell Carcinoma in a Cohort of People Living With HIV from 2004 to 2017: Implementation of a Screening Program.
    Milanés Guisado Y; Sotomayor C; Fontillón M; Domínguez Castaño A; Espinosa N; Roca C; López-Cortés LF; Viciana P; Neukam K;
    Dis Colon Rectum; 2022 Jan; 65(1):28-39. PubMed ID: 34694279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?
    Malakorn S; Yang Y; Bednarski BK; Kaur H; You YN; Holliday EB; Dasari A; Skibber JM; Rodriguez-Bigas MA; Chang GJ
    Dis Colon Rectum; 2019 Oct; 62(10):1158-1166. PubMed ID: 31490825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does IBD Portend Worse Outcomes in Patients with Rectal Cancer? A Case-Matched Analysis.
    Alsughayer A; Grass F; McKenna NP; Petersen M; Mathis KL; Lightner AL
    Dis Colon Rectum; 2020 Sep; 63(9):1265-1275. PubMed ID: 33216497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Resolution Anoscopy Surveillance After Anal Squamous Cell Carcinoma: High-Grade Squamous Intraepithelial Lesion Detection and Treatment May Influence Local Recurrence.
    Cappello C; Cuming T; Bowring J; Rosenthal AN; Chindawi N; Nathan M
    Dis Colon Rectum; 2020 Oct; 63(10):1363-1371. PubMed ID: 32969879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.